Table 1 Demographic and clinical characteristics of pediatric patients diagnosed with paroxysmal sympathetic hyperactivity
Variables (N = 42) | Counts | % of Total |
|---|---|---|
Age in years | ||
Mean (SD) | 6.53 | 3.883 |
Median (IQR) | 6 | (4, 9) |
Age of PSH onset in years (N = 41) | ||
Mean (SD) | 4.195 | 3.308 |
Median (IQR) | 3 | (2, 5) |
Gender | ||
Male | 28 | 66.7% |
Female | 14 | 33.3% |
Gestational age | ||
Preterm | 4 | 9.5% |
Term | 38 | 90.5% |
Developmental status at the time of suspension of PSH | ||
Appropriate for age | 11 | 26.2% |
Global developmental delay | 31 | 73.8% |
History of brain insult | ||
Yes | 23 | 54.8% |
No | 19 | 45.2% |
Type of brain insult | ||
HIE | 13 | 31.0% |
Viral Encephalitis | 1 | 2.4% |
Autoimmune encephalitis | 2 | 4.76% |
Traumatic Brain Injury | 5 | 11.9% |
bacterial meningitis | 1 | 2.4% |
CHARGE syndrome with post-meningitis hydrocephalus | 1 | 2.4% |
None | 19 | 45.2% |
PSH Etiology | ||
Traumatic | 5 | 11.9% |
Non-traumatic | 37 | 88.1% |
Feeding | ||
Per oral | 4 | 9.5% |
Nasogastric tube | 4 | 9.5% |
Gastrostomy tube | 34 | 81.0% |
Comorbidities | ||
Epilepsy | 28 | 66.7% |
Spasticity | 38 | 90.5% |
GERD | 38 | 90.5% |